CD274 and neoplasm: Based on this evidence, addition of PD-1/PD-L1 inhibitor to platinum- containing chemotherapy is strongly recommended in patients with PS 0–1 when their tumor is driver oncogene-negative and PD-L1 is < 50%, or unknown.